Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.14% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPAI
6351
Safe Pro Group Inc
SPAI
$97.5M
| $36.7K | ﹤0.01% |
8,817
+8,312
| +1,646% | +$45.7K |
|
6352
Ampco-Pittsburgh
AP
$195M
| $36.6K | ﹤0.01% |
6,871
+628
| +10% | +$1.74K |
|
6353
Atossa Therapeutics
ATOS
$24.9M
| $36.3K | ﹤0.01% |
4,100
-3,390
| -45% | -$42.9K |
|
|
IMOS
6354
ChipMOS TECHNOLOGIES
IMOS
$2.02B
| $36.1K | ﹤0.01% |
1,219
-470
| -28% | -$11.7K |
|
|
KRKR
6355
36Kr Holdings
KRKR
$6.1M
| $35.9K | ﹤0.01% |
7,539
+617
| +9% | +$3.26K |
|
6356
CapForce IBD 50 ETF
FFTY
$80.5M
| $35.8K | ﹤0.01% |
1,029
+133
| +15% | +$4.9K |
|
|
KZR
6357
DELISTED
Kezar Life Sciences
KZR
| $35.8K | ﹤0.01% |
5,685
-2,135
| -27% | -$12.5K |
|
6358
Freightos
CRGO
$66.7M
| $35.7K | ﹤0.01% |
15,652
+6,851
| +78% | +$22.2K |
|
6359
Quince Therapeutics
QNCX
$33.9M
| $35.6K | ﹤0.01% |
53
+35
| +194% | +$17.6K |
|
6360
AdvisorShares Pure Cannabis ETF
YOLO
$33.5M
| $35.5K | ﹤0.01% |
10,768
-2,375
| -18% | -$7.67K |
|
|
OZEM
6361
Roundhill GLP-1 & Weight Loss ETF
OZEM
$64.6M
| $35.5K | ﹤0.01% |
1,039
| – | – |
|
|
CRT
6362
Cross Timbers Royalty Trust
CRT
$60.1M
| $35.3K | ﹤0.01% |
4,437
-26,317
| -86% | -$210K |
|
6363
Franklin FTSE Taiwan ETF
FLTW
$3.23B
| $35.2K | ﹤0.01% |
579
+11
| +2% | +$664 |
|
6364
Ultralife
ULBI
$121M
| $35.2K | ﹤0.01% |
6,147
-399
| -6% | -$2.46K |
|
|
ACFN
6365
Acorn Energy
ACFN
$45.6M
| $34.9K | ﹤0.01% |
2,312
+2,000
| +641% | +$38.5K |
|
|
CIRC
6366
Circle8 Group
CIRC
$61.4M
| $34.8K | ﹤0.01% |
26,130
+19,101
| +272% | +$44.3K |
|
6367
Knightscope
KSCP
$31.4M
| $34.7K | ﹤0.01% |
9,342
+9,031
| +2,904% | +$45.9K |
|
6368
Annovis Bio
ANVS
$76.1M
| $34.3K | ﹤0.01% |
9,901
+2,512
| +34% | +$7.55K |
|
6369
Inspire 500 ETF
PTL
$913M
| $34.3K | ﹤0.01% |
138
| – | – |
|
|
TOPT
6370
iShares Top 20 U.S. Stocks ETF
TOPT
$680M
| $34.2K | ﹤0.01% |
1,096
+746
| +213% | +$23.1K |
|
6371
iPath Series B Carbon Exchange-Traded Notes
GRN
$23.7M
| $34.2K | ﹤0.01% |
1,000
| – | – |
|
|
SPRB
6372
Spruce Biosciences
SPRB
$141M
| $33.8K | ﹤0.01% |
388
+290
| +296% | +$31.1K |
|
6373
ProShares Ultra Bloomberg Crude Oil
UCO
$428M
| $33.8K | ﹤0.01% |
1,748
-219,534
| -99% | -$4.5M |
|
6374
BondBloxx Bloomberg Ten Year Target Duration US Treasury ETF
XTEN
$1.05B
| $33.7K | ﹤0.01% |
728
+700
| +2,500% | +$32.7K |
|
|
LZMH
6375
LZ Technology Holdings
LZMH
$10.8M
| $33.5K | ﹤0.01% |
1,010
-141
| -12% | -$7.61K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.